首页> 美国卫生研究院文献>AAPS PharmSci >The Twofold Advantage of the Amorphous Form as an Oral Drug Delivery Practice for Lipophilic Compounds: Increased Apparent Solubility and Drug Flux Through the Intestinal Membrane
【2h】

The Twofold Advantage of the Amorphous Form as an Oral Drug Delivery Practice for Lipophilic Compounds: Increased Apparent Solubility and Drug Flux Through the Intestinal Membrane

机译:作为亲脂性化合物的口服药物递送方式无定形形式的双重优势:通过肠膜的表观溶解度和药物通量增加。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purposes of this study were to assess the efficiency of different nifedipine amorphous solid dispersions (ASDs) in achieving and maintaining supersaturation and to investigate the solubility–permeability interplay when increasing the apparent solubility via ASD formulations. Spray-dried ASDs of nifedipine in three different hydrophilic polymers, hydroxypropyl methylcellulose acetate succinate (HPMC-AS), copovidone, and polyvinylpyrrolidone (PVP), were prepared and characterized by powder X-ray diffraction and differential scanning calorimetry. The ability of these formulations to achieve and maintain supersaturation over 24 h was assessed. Then, nifedipine’s apparent intestinal permeability was investigated as a function of increasing supersaturation in the parallel artificial membrane permeability assay model and in the single-pass rat intestinal perfusion model. The efficiency of the different ASDs to achieve and maintain supersaturation of nifedipine was found to be highly polymer dependent; while a dispersion in HPMC-AS enabled supersaturation 20× that of the crystalline aqueous solubility, a dispersion in copovidone enabled 10×, and PVP allowed supersaturation of only 5× that of the crystalline solubility. Nifedipine flux across the intestine from supersaturated solutions was increased, and the apparent intestinal permeability was constant, irrespective of the degree of supersaturation or the polymer being used. In conclusion, while with other solubility-enabling approaches (e.g., surfactants, cyclodextrins, cosolvents), it is not enough to increase the apparent solubility, but to strike the optimal solubility–permeability balance, which limits the chances for successful drug delivery, the amorphous form emerges as a more advantageous strategy, in which higher apparent solubility (i.e., supersaturation) will be readily translated into higher drug flux and overall absorption.
机译:这项研究的目的是评估不同硝苯地平无定形固体分散体(ASD)达到和维持过饱和的效率,并研究通过ASD配方增加表观溶解度时的溶解度-渗透性相互作用。制备了硝苯地平在三种不同的亲水性聚合物(羟丙基甲基纤维素乙酸琥珀酸酯(HPMC-AS),共聚维酮和聚乙烯吡咯烷酮(PVP))中喷雾干燥的ASD,并通过粉末X射线衍射和差示扫描量热法进行了表征。评估了这些制剂在24小时内达到并保持过饱和的能力。然后,在平行人工膜通透性测定模型和单次通过大鼠肠灌注模型中,研究了硝苯地平的表观肠通透性与增加过饱和度的关系。人们发现,不同的ASD实现和维持硝苯地平过饱和的效率高度依赖于聚合物。而HPMC-AS中的分散体可使结晶水溶液的溶解度提高20倍,而在共聚维酮中的分散体可使结晶度的溶解度提高10倍,而PVP的过饱和度仅为结晶度溶解度的5倍。硝苯地平从过饱和溶液穿过肠道的通量增加,并且表观肠通透性恒定,与过饱和程度或使用的聚合物无关。总而言之,尽管采用其他可提高溶解度的方法(例如表面活性剂,环糊精,助溶剂),增加表观溶解度还不够,但要达到最佳的溶解度-渗透率平衡,这限制了药物成功递送的机会,无定形形式作为一种更有利的策略出现,其中较高的表观溶解度(即过饱和)将很容易转化为较高的药物通量和总吸收。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号